Building a Diagnostics Territory Account Plan

A diagnostics territory account plan is more than a list of accounts, pipeline stages, and visit targets. It is a working point of view on how laboratories, clinical teams, veterinary practices, health systems, and animal-health organizations make decisions—and how you can help the right stakeholders evaluate a legitimate operational fit.

For medical and veterinary sales professionals, the strongest plan connects territory priorities to the customer’s testing workflow: specimen collection, ordering, transport, analysis, result delivery, quality processes, and follow-up. It also keeps commercial activity inside appropriate product labeling, promotional review, privacy practices, and employer policies. In human diagnostics, in vitro diagnostic products are regulated medical devices, and laboratories that test human specimens operate within the Clinical Laboratory Improvement Amendments framework. FDA’s overview of IVD regulation and CDC’s CLIA resources are useful grounding references when you are learning the environment your accounts work in.

Start with a territory thesis, not a call list

Your territory thesis is a concise explanation of where you expect to create the most appropriate value, why, and what you need to learn to validate that view. It should guide account selection without assuming every organization has the same workflow or needs.

A useful thesis identifies:

• Customer segments: for example, physician-office laboratories, hospital laboratories, integrated delivery networks, reference-lab clients, specialty practices, veterinary hospitals, production-animal organizations, or university and public animal-health laboratories.
• Workflow settings: centralized testing, near-patient testing, send-out testing, routine screening workflows, specialty testing, or surveillance-related work.
• Business triggers: service concerns, a new clinical program, workflow redesign, instrument lifecycle planning, supply standardization, changes in testing demand, or an interest in consolidating vendors.
• Your legitimate contribution: a product or service capability that is supported by approved materials and may fit a documented customer objective.
• Knowledge gaps: what must be confirmed with the customer before you recommend a next step.

Keep the thesis provisional. A territory plan becomes unreliable when public signals, past notes, or a familiar account name are treated as proof of a present need. Use them to prepare better questions, not to pre-decide the solution.

Build a practical account universe

Divide the territory into tiers based on strategic fit, access, timing, and the amount of customer discovery still required. Tiers are a planning tool, not a judgment about the importance of a practice or laboratory.

Tier accounts by evidence and actionability

For each account, capture a brief profile that separates verified facts from assumptions. Include the customer type, care setting or animal-health setting, laboratory model, known test pathways, relevant contacts, incumbent approach when known, pending initiatives, barriers to access, and the next learning objective.

Then classify accounts in a way that directs your time:

• Priority accounts: clear strategic fit and a defined discovery or advancement action.
• Development accounts: plausible fit, but limited evidence, access, or timing.
• Maintain accounts: existing relationships or activity that require disciplined follow-through without consuming disproportionate attention.
• Monitor accounts: organizations where a trigger may emerge later and light-touch research is appropriate.

Do not confuse size with priority. An account can be strategically important because it is influential, geographically central, operationally complex, clinically specialized, or aligned with your employer’s approved focus. The exact segmentation rules, account ownership, and call expectations are employer-specific; use the company’s current guidance rather than importing a framework from a prior role.

Map the diagnostic workflow before mapping the stakeholders

Stakeholder maps are valuable, but they are stronger when built around the work that must happen. Start by sketching the path from test consideration through result use. This helps you identify who experiences the problem, who controls the process, who owns validation or quality activities, who manages contracting, and who needs to approve implementation.

In a human-health setting, possible perspectives may include laboratory leadership, pathologists, clinical service-line leaders, nursing or point-of-care leaders, supply chain, information technology, finance, procurement, and compliance. In veterinary settings, the mix can include veterinarians, practice managers, technicians, laboratory contacts, operations leaders, owners, and, in animal-health or production contexts, additional diagnostic and regulatory stakeholders.

Do not assign authority based solely on title. Ask respectful, open questions: Who owns this workflow? Who would need to assess operational readiness? Who receives and acts on the results? Which team would need to be involved if the process changed? Who can explain the current approval path?

Veterinary diagnostic territory planning may require extra attention to sample handling, submission information, and referral pathways. For example, Cornell University’s Animal Health Diagnostic Center emphasizes accurate labeling, suitable storage, shipping, and clinical history as contributors to useful diagnostic submissions. Its sample-submission guidance is a helpful reminder that the pre-analytical workflow deserves discovery, not assumptions.

Turn discovery into an account hypothesis

An account hypothesis is not a pitch. It is a testable statement that links a customer objective or friction point to a possible next conversation. It should be updated as new information becomes available.

A simple structure is:

• Observed signal: what you know from a credible interaction, approved account record, or public source.
• Possible impact: the workflow, service, quality, access, or coordination issue that may be worth exploring.
• Discovery questions: the information you need before proposing any pathway.
• Appropriate resource: approved clinical, technical, implementation, or service support that may help answer the customer’s question.
• Mutual next step: a specific meeting, workflow review, technical discussion, or follow-up agreed with the account.

For diagnostics, strong discovery often explores specimen requirements, ordering and result-routing steps, testing location, turnaround expectations, quality processes, interfaces, training needs, supply continuity, and implementation ownership. The point is not to conduct a laboratory assessment outside your role. It is to understand which questions require the customer’s technical experts and which approved internal resources should join the conversation.

Use evidence responsibly

Diagnostics selling depends on precision. Claims about performance, intended use, limitations, regulatory status, or workflow impact must match the product’s current labeling and employer-approved materials. FDA notes that IVDs are subject to premarket and postmarket controls and that labeling has specific requirements. FDA’s IVD resource center also provides pathways to product and decision-summary databases that can support responsible preparation.

Build an evidence folder for each priority account or opportunity, using only materials you are authorized to use. It may include approved product information, implementation documents, relevant scientific literature cleared for external use, service documentation, and notes from customer conversations. Label what is confirmed, what is customer-reported, and what remains to be validated.

For veterinary and animal-health accounts, recognize that some testing pathways have public-health, surveillance, or approval implications. The U.S. Department of Agriculture’s National Animal Health Laboratory Network supports surveillance and diagnostic response and describes quality, standardized testing, competency, communications, and biosafety as core principles. Review the USDA APHIS NAHLN overview when it is relevant to your account environment. Do not imply that a product or laboratory has a designation, approval, or use case unless you can verify it through authoritative, approved sources.

Create account plays around customer decisions

Rather than repeating the same product presentation, create a small number of account plays tied to a customer decision. A play is a repeatable sequence of learning, stakeholder engagement, and approved resources—not a scripted pressure tactic.

Examples of decision-centered plays

• Workflow discovery play: confirm the current process, handoffs, bottlenecks, and the stakeholders who should evaluate alternatives.
• Technical evaluation play: coordinate an approved discussion with appropriate technical or clinical personnel after the customer identifies a specific question.
• Implementation-readiness play: identify ownership, training, connectivity, logistics, service, and timeline considerations before a customer commits to change.
• Existing-account optimization play: review agreed service topics, education needs, utilization questions, or issue-escalation paths within your role and company policy.
• Veterinary referral or submission play: explore how samples, history, results, and communication move between a practice and diagnostic laboratory, without giving clinical direction.

Each play should include a clear stop condition. If there is no verified need, no access to the relevant stakeholders, no approved pathway, or no customer interest in a next step, document what you learned and redirect effort appropriately.

Plan the internal work as carefully as the customer work

Complex diagnostics opportunities often require coordination across commercial, technical, clinical, service, contracting, implementation, and leadership teams. Your account plan should make that coordination visible early.

For every priority opportunity, define:

• the customer decision to be supported;
• the internal subject-matter expertise needed;
• the approved materials or documentation required;
• the owner of each follow-up;
• the risks that need review, such as claims, privacy, contracting, or implementation scope; and
• the next customer-facing action and the condition for advancing it.

This prevents a common failure mode: bringing an internal expert into a meeting before the customer question, account context, and desired outcome are clear. A concise internal briefing improves relevance and helps colleagues prepare within their own responsibilities.

Measure progress with leading indicators

Revenue and closed business matter, but they are lagging outcomes. A territory account plan is more useful when it also tracks whether you are improving the quality of your work.

Choose a small, employer-approved set of indicators that show progress, such as stakeholder coverage, completed discovery, validated workflow facts, agreed next steps, internal resource alignment, documented barriers, and opportunity-stage movement. Review them alongside account notes. If activity is high but learning is low, improve the questions. If opportunities stall after technical conversations, revisit stakeholder alignment and implementation readiness.

Run a consistent review rhythm

Set aside regular time to review each priority account. Update the account hypothesis, check whether the next step is still mutual and relevant, identify changes in stakeholders or timing, and remove unsupported assumptions. Periodically reassess the overall territory: which segments are producing credible discovery, which accounts need a different approach, and where should you stop spending effort?

A ROOK career resource can help you treat territory planning as a professional discipline: prepare thoroughly, listen for workflow realities, use approved evidence, coordinate the right expertise, and document what you learn. The result is a territory account plan that is commercially organized while remaining credible with the laboratory and clinical professionals it is meant to serve.

Account-plan checklist

• Have I separated confirmed account facts from assumptions?
• Can I describe the relevant diagnostic workflow in plain language?
• Do I know which stakeholders experience, own, approve, and implement the process?
• Is my proposed value discussion consistent with current approved claims and product information?
• Have I identified the internal expertise required before advancing the conversation?
• Is the next step specific, appropriate, mutually understood, and documented?
• Have I recorded a reason to pause or disqualify the opportunity if evidence is insufficient?